vancomycin has been researched along with carvacrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalcante, TTA; Costa, RA; de Carvalho, MG; de Sousa, OV; Júnior, FEAC; Melo, HM; Menezes, FGR; Vasconcelos, SECB | 1 |
| Abo-Youssef, AM; Hassan, SM; Khalaf, MM; Sayed, AM | 1 |
1 trial(s) available for vancomycin and carvacrol
| Article | Year |
|---|---|
Carvacrol mitigates vancomycin-induced nephrotoxicity via regulation of IkBα/p38MAPK and Keap1/Nrf2 signaling pathways: an experimental study with in silico evidence.
Topics: Animals; Kelch-Like ECH-Associated Protein 1; Kidney; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Vancomycin | 2022 |
1 other study(ies) available for vancomycin and carvacrol
| Article | Year |
|---|---|
Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Biofilms; Cymenes; Drug Resistance, Bacterial; Humans; Monoterpenes; Oils, Volatile; Oxacillin; Plant Extracts; Plant Leaves; Plectranthus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |